To include your compound in the COVID-19 Resource Center, submit it here.
Regulus said FDA issued a request for information related to the clinical hold on RG-101. The agency requested a detailed safety
Sign in to your BioCentury account to access your content.
Get a two-week free trial subscription to BioCentury